This observation suggests that not only might changes in splicing activity be the driver of this disease, but also other underlying mechanisms that likely play important roles in the pathogenesis of RBM20-related cardiomyopathy exist [3,9,19,22,33]. This evidence concerns the gene RBM20 and cardiomyopathy.